All News #Library
Biotech
Glyscend Doses First GLY-200 Obesity Phase 2 Patient
03 Jun 2024 //
BUSINESSWIRE
Glyscend Announces Positive Topline Phase 2a Clinical Results of GLY-200
31 May 2023 //
BUSINESSWIRE
Glyscend Appoints Biotech Industry Veteran Michael Wyzga to Board of Directors
30 Mar 2023 //
BUSINESSWIRE

Market Place
Sourcing Support